Examples of 'tenofovir alafenamide' in a sentence
Meaning of "tenofovir alafenamide"
Tenofovir alafenamide is a medication used to treat HIV/AIDS and hepatitis B by preventing the virus from multiplying in the body. It belongs to the class of antiretroviral drugs known as nucleotide reverse transcriptase inhibitors
How to use "tenofovir alafenamide" in a sentence
Basic
Advanced
tenofovir alafenamide
Tenofovir alafenamide is eliminated following metabolism to tenofovir.
Interaction not studied with tenofovir alafenamide.
Effect of tenofovir alafenamide on other medicinal products.
It contains the active substance tenofovir alafenamide.
Tenofovir alafenamide was not mutagenic or clastogenic in conventional genotoxicity assays.
It is not known whether tenofovir alafenamide is an inhibitor of other.
The active substances are emtricitabine and tenofovir alafenamide.
It is not known whether tenofovir alafenamide is excreted in human milk.
Vemlidy contains the active substance tenofovir alafenamide.
Tenofovir alafenamide fumarate is mainly eliminated following metabolism to tenofovir.
Medicinal products that may affect tenofovir alafenamide.
Tenofovir alafenamide was not mutagenic or clastogenic in conventional genotoxic assays.
The active substance is tenofovir alafenamide.
Tenofovir alafenamide hemifumarate is preferably administered as part of a pharmaceutical composition or formulation.
It is not known whether tenofovir alafenamide is secreted in human milk.
See also
Descovy contains the active substances emtricitabine and tenofovir alafenamide.
In one embodiment is provided tenofovir alafenamide hemifumarate in a solid form.
Tenofovir alafenamide had a milder effect on the kidney than tenofovir disoproxil.
In one embodiment of the invention is provided tenofovir alafenamide hemifumarate.
Emtricitabine and tenofovir alafenamide demonstrated synergistic antiviral activity in cell culture.
Animal studies do not indicate harmful effects of tenofovir alafenamide on fertility.
The antiviral activity of tenofovir alafenamide against laboratory and clinical isolates of.
No pharmacokinetic data are available for emtricitabine and tenofovir alafenamide during pregnancy.
Tenofovir alafenamide any other antiviral medicines that contain lamivudine or adefovir dipivoxil.
It is not known whether rilpivirine or tenofovir alafenamide are excreted in human milk.
Tenofovir alafenamide is a substrate of OATP in vitro.
It is not known whether bictegravir or tenofovir alafenamide is excreted in human milk.
Tenofovir alafenamide This medicine is subject to additional monitoring.
In one embodiment is provided tenofovir alafenamide hemifumarate for use in medical therapy.
Tenofovir alafenamide is commonly known as TAF.
The safety of emtricitabine and tenofovir alafenamide has not been established in these patients.
Tenofovir alafenamide for hepatitis B shows improved kidney and bone safety after a year.
No antagonism was observed with emtricitabine or tenofovir alafenamide when combined with other antiretroviral agents.
The active substances are emtricitabine, rilpivirine and tenofovir alafenamide.
The hemifumarate form of tenofovir alafenamide is also referred to herein as tenofovir alafenamide hemifumarate.
The active substances are bictegravir, emtricitabine and tenofovir alafenamide.
It is not known whether tenofovir alafenamide is an inhibitor of other UGT enzymes.
The active substances are elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide.
Chemical stability of the hemifumarate form of tenofovir alafenamide was compared with the monofumarate form.
Tenofovir alafenamide is primarily hydrolysed to form tenofovir by carboxylesterase 1 in primary hepatocytes.
In another embodiment is provided tenofovir alafenamide hemifumarate for use to treat an HIV infection.
Tenofovir alafenamide hemifumarate may also be presented as a bolus, electuary, or paste.
Co-administration of rifabutin may decrease tenofovir alafenamide plasma concentrations.
Co-administration of fluconazole or isavuconazole may increase plasma concentrations of tenofovir alafenamide.
Metabolism is a major elimination pathway for tenofovir alafenamide in humans, accounting for.
In one embodiment, tenofovir alafenamide hemifumarate can be prepared using selective crystallization.
Co-administration of rifampicin may decrease tenofovir alafenamide plasma concentrations.
In particular, tenofovir alafenamide may be associated with fumarate, such as monofumarate or hemifumarate.
Co-administration is not recommended due to the expected decrease of tenofovir alafenamide.
Elvitegravir, emtricitabine, and tenofovir alafenamide demonstrated synergistic antiviral activity in cell culture.
You'll also be interested in:
Examples of using Tenofovir
Show more
Tenofovir is principally eliminated via the kidney
Interaction not studied with tenofovir alafenamide
With tenofovir disoproxil fumarate or with emtricitabine
Examples of using Alafenamide
Show more
Tenofovir alafenamide is eliminated following metabolism to tenofovir
Interaction not studied with tenofovir alafenamide
Effect of tenofovir alafenamide on other medicinal products
